These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18221298)

  • 1. Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Viral Hepat; 2008 Jun; 15(6):459-70. PubMed ID: 18221298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional evaluation of dendritic cell vaccines based on different hepatitis C virus nonstructural genes.
    Tian Y; Zhang HH; Wei L; Du SC; Chen HS; Fei R; Liu F
    Viral Immunol; 2007 Dec; 20(4):553-61. PubMed ID: 18158729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
    Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
    Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice.
    Holmström F; Pasetto A; Nähr V; Brass A; Kriegs M; Hildt E; Broderick KE; Chen M; Ahlén G; Frelin L
    J Immunol; 2013 Feb; 190(3):1113-24. PubMed ID: 23284053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein.
    Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P
    Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.
    Yu H; Huang H; Xiang J; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2006 Jan; 87(Pt 1):1-10. PubMed ID: 16361412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells.
    Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P
    Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection.
    Encke J; Bernardin J; Geib J; Barbakadze G; Bujdoso R; Stremmel W
    World J Gastroenterol; 2006 Nov; 12(44):7118-25. PubMed ID: 17131473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice.
    Guan J; Deng Y; Chen H; Yin X; Yang Y; Tan W
    Arch Virol; 2015 Oct; 160(10):2517-24. PubMed ID: 26215441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunization.
    Masalova OV; Lesnova EI; Pichugin AV; Melnikova TM; Grabovetsky VV; Petrakova NV; Smirnova OA; Ivanov AV; Zaberezhny AD; Ataullakhanov RI; Isaguliants MG; Kushch AA
    Vaccine; 2010 Feb; 28(8):1987-96. PubMed ID: 20188254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
    Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
    J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells.
    Wintermeyer P; Gehring S; Eken A; Wands JR
    J Viral Hepat; 2010 Oct; 17(10):705-13. PubMed ID: 20002303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.
    Xiang M; Eisenbach C; Lupu CM; Ernst E; Stremmel W; Encke J
    Viral Immunol; 2006; 19(2):210-9. PubMed ID: 16817764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
    Encke J; zu Putlitz J; Geissler M; Wands JR
    J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response].
    Masalova OV; Lesnova EI; Grabovetskiĭ VV; Smirnova OA; Ulanova TI; Burkov AN; Ivanov AV; Zaberezhnyĭ AD; Ataullakhanov RI; Kushch AA
    Mol Biol (Mosk); 2010; 44(2):275-83. PubMed ID: 20586188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
    Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.